- Home
- CDT vs SSY Comparison
CDT vs SSY Comparison
Compare CDT & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- SSY
- Stock Information
- Founded
- CDT 2019
- SSY 1959
- Country
- CDT United States
- SSY United States
- Employees
- CDT N/A
- SSY N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- CDT Health Care
- SSY Health Care
- Exchange
- CDT Nasdaq
- SSY Nasdaq
- Market Cap
- CDT 5.3M
- SSY 6.3M
- IPO Year
- CDT N/A
- SSY N/A
- Fundamental
- Price
- CDT $0.39
- SSY $0.83
- Analyst Decision
- CDT
- SSY
- Analyst Count
- CDT 0
- SSY 0
- Target Price
- CDT N/A
- SSY N/A
- AVG Volume (30 Days)
- CDT 768.1K
- SSY 8.5K
- Earning Date
- CDT 05-15-2025
- SSY 05-13-2025
- Dividend Yield
- CDT N/A
- SSY N/A
- EPS Growth
- CDT N/A
- SSY N/A
- EPS
- CDT N/A
- SSY 0.25
- Revenue
- CDT N/A
- SSY $31,094,000.00
- Revenue This Year
- CDT N/A
- SSY N/A
- Revenue Next Year
- CDT N/A
- SSY N/A
- P/E Ratio
- CDT N/A
- SSY $3.51
- Revenue Growth
- CDT N/A
- SSY N/A
- 52 Week Low
- CDT $0.51
- SSY $0.53
- 52 Week High
- CDT $350.00
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- CDT 31.63
- SSY 40.61
- Support Level
- CDT $0.38
- SSY $0.82
- Resistance Level
- CDT $0.41
- SSY $0.87
- Average True Range (ATR)
- CDT 0.04
- SSY 0.04
- MACD
- CDT 0.01
- SSY -0.01
- Stochastic Oscillator
- CDT 9.89
- SSY 3.16
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.